FactorPad
Build a Better Process

Stock Risk Measures for Intersect Ent Inc

A quantitative factor review as of June 30, 2021.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
face pic by Paul Alan Davis, CFA
Updated: July 06, 2021
See how we arrive at an overall risk score of 84 for XENT below.

/ factorpad.com / stocks / f73hvx.html


An ad-free and cookie-free website.


XENT Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Intersect Ent Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how XENT stock compares to 2,000+ US-based stocks, and to peers in the Manufacturing sector and Medicinal and Botanical Manufacturing industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Intersect ENT is a global ear, nose and throat medical technology leader dedicated to transforming patient care. The Company's steroid releasing implants are designed to provide mechanical spacing and deliver targeted therapy to the site of disease. In addition, Intersect ENT is continuing to expand its portfolio of products based on the Company's unique localized steroid releasing technology and is committed to broadening patient access to less invasive and more cost-effective care. In October 2020, Intersect ENT acquired Fiagon AG Medical Technologies, a global leader in electromagnetic surgical navigation solutions with an expansive portfolio of ENT product offerings, including the VENSURE sinus balloon, that complement the Company's PROPEL® and SINUVA® sinus implants and extend its geographic reach.

Identity

Sector and Industry

Share Data

Shares

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f73hvx.html


XENT stock risk
INTERSECT ENT INC stock beta
XENT risk report
XENT f73hvx
XENT risk analysis
XENT volatility
INTERSECT ENT INC credit risk
XENT liquidity risk
XENT leverage
XENT valuation
XENT systematic risk
XENT specific risk
INTERSECT ENT INC volatility
XENT analysis
XENT financial ratio

A newly-updated free resource. Connect and refer a friend today.